Stem cells can regrow hair, but the technology is still experimental and not yet approved by any major regulatory agency for treating hair loss. Early clinical studies show promising results, with one Italian trial reporting a 29% increase in hair density about 23 weeks after treatment. That’s a meaningful improvement, but the field is still years away from offering a reliable, widely available solution.
How Stem Cells Activate Hair Growth
Your hair follicles already contain stem cells. They sit in a region called the bulge, near the top of each follicle, and their job is to regenerate hair during the normal growth cycle. Hair naturally cycles between a growing phase (anagen), a transition phase, and a resting phase (telogen). The shift from resting to growing depends on chemical signals, particularly proteins in the Wnt family, that tell stem cells to wake up and start dividing.
When Wnt signaling ramps up, follicle stem cells begin proliferating and differentiating into the specialized cells that build a new hair shaft. This pathway is considered the key driver for pushing follicles from rest into active growth and plays a role in every stage of follicle development. In pattern hair loss, these signals weaken over time as follicles miniaturize, producing thinner, shorter hairs until they eventually stop growing visible hair altogether.
The critical detail for anyone considering stem cell therapy: in androgenetic alopecia (the common genetic pattern baldness affecting both men and women), the stem cells themselves are still intact. It’s the progenitor cells downstream that become damaged. That distinction is what makes pattern hair loss potentially reversible with stem cell approaches, unlike scarring forms of alopecia where the stem cell reservoir itself is destroyed.
What Stem Cell Hair Treatments Look Like
There is no single “stem cell hair treatment.” Several different approaches are being studied, and they differ in where the cells come from and how they’re used.
- Autologous follicle stem cells: A small punch biopsy is taken from your own scalp, trimmed, and centrifuged to separate the stem cells. The resulting cell suspension is then injected about 5 millimeters deep into thinning areas. In one study of 11 patients, this approach increased hair density by 29%.
- Adipose-derived stem cells: Fat tissue harvested through a small liposuction procedure is processed to isolate a concentrated mix rich in mesenchymal stem cells. This is injected into the scalp in a grid pattern, roughly 1 milliliter per square centimeter. Research has shown increased hair growth and density over three to six months.
- PRP (platelet-rich plasma): While not technically a stem cell therapy, PRP is often discussed alongside these treatments and sometimes combined with them. It uses growth factors from your own blood. Studies show it increases hair density by approximately 29%, comparable to the stem cell results seen so far.
Lab research suggests adipose-derived stem cells may have an edge over PRP. When scientists compared the two in cell cultures, the stem cell approach significantly outperformed PRP in stimulating the proliferation and migration of dermal papilla cells, the specialized cells at the base of each follicle that control hair growth. It also boosted the expression of key proteins involved in hair-producing ability by two to three times compared to controls.
Results, Cost, and Timeline
The most-cited clinical data comes from an Italian study showing a 29% increase in hair density 23 weeks after the final treatment. A separate South Korean transplant study found a 28.1% increase after 16 weeks. These are encouraging numbers, but they come from small studies. For comparison, topical minoxidil (the over-the-counter treatment most people try first) typically produces only a 0.4% to 2% increase in hair density.
Multiple sessions are generally needed, spaced over several months, and results are not guaranteed. Clinics currently offering investigational stem cell hair treatments charge between $3,000 and $10,000, though costs can reach $25,000 depending on the extent of hair loss being treated. Insurance does not cover these procedures.
Who Responds Best
Not all hair loss is equally suited to stem cell treatment. Pattern hair loss (androgenetic alopecia) is the most promising candidate because the follicle stem cells remain undamaged. One study found that treatment was actually more effective in patients over 51 and those with moderate severity of hair loss, not the earliest or most advanced stages. This suggests there may be a sweet spot where follicles have miniaturized enough to benefit from reactivation but haven’t been dormant so long that the surrounding tissue can no longer support regrowth.
Alopecia areata, the autoimmune form of hair loss that causes patchy bald spots, has also been studied. Some research shows improvements in hair density for these patients after stem cell injections, though the evidence is thinner. Scarring alopecias, where the follicle stem cells themselves are destroyed by inflammation, are unlikely to benefit from these approaches.
What’s Not Available Yet
The most exciting long-term prospect is hair follicle cloning: taking a small number of your healthy follicles, multiplying them in a lab, and transplanting the new follicles into bald areas. Scientists have successfully cloned hair follicles from a patient’s own cells in laboratory settings, which reduces the risk of rejection. But the technique is still experimental. Researchers are working on scaling up the process to produce enough follicles for meaningful coverage, and no commercial product is available.
It’s worth being clear about the regulatory picture. Topical minoxidil and oral finasteride remain the only two FDA-approved treatments for pattern hair loss. No stem cell therapy for hair regrowth has received FDA approval. Clinics offering these treatments are doing so on an investigational or off-label basis, and the quality and protocols vary widely from one provider to the next.
Practical Takeaways
Stem cells can regrow hair in clinical settings, and the early data is more compelling than what conventional topical treatments offer. A 29% density increase versus minoxidil’s 0.4% to 2% is a significant gap. But the studies are small, the treatments are expensive, results take months to appear, and there is no regulatory stamp of approval ensuring consistent quality across clinics. If you’re considering this route, look for providers conducting formal clinical trials or using well-documented protocols with published outcomes, rather than clinics making broad promises based on the general concept of stem cells.